Floatz logo

Immunoglobulin G1, anti-(human/Macaca fascicularis/Macaca mulatta killer cell lectin-like receptor KLRD1) (human monoclonal DR-01 ?1-chain), disulfide with human monoclonal DR-01 ?-chain, dimer

Extranodal NK/T Cell Lymphoma, Nasal Type

Dren Biomonoclonal_antibodyPhase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

52 Active assets in the Extranodal NK/T Cell Lymphoma, Nasal Type cohort.

Asset / SponsorPhaseRating
PEGASPARGASE
CStone Pharmaceuticals
Phase 4BBB
DEXAMETHASONE
Mingzhi Zhang
Phase 4BBB
CIS-DIAMMINEDICHLOROPLATINUM II
National Cancer Centre, Singapore
Phase 4BBB
ETOPOSIDE
Tarapeutics Science Inc.
Phase 4BB
Tucidinostat
Ruijin Hospital
Phase 4BB

View all 50 →

Same molecule, other indications

Immunoglobulin G1, anti-(human/Macaca fascicularis/Macaca mulatta killer cell lectin-like receptor KLRD1) (human monoclonal DR-01 ?1-chain), disulfide with human monoclonal DR-01 ?-chain, dimer is also rated in:

primary cutaneous gamma-delta t-cell lymphomaDormant
CCC
Indicative ·
48 / 100
View asset →
primary cutaneous aggressive epidermotropic CD8+ T-cell lymphomaDormant
CCC
Indicative ·
48 / 100
View asset →
T-cell large granular lymphocyte leukemiaDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →